PMC:7242007 / 3675-4395
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
225 | 60-68 | Species | denotes | patients | Tax:9606 |
226 | 137-145 | Species | denotes | patients | Tax:9606 |
227 | 286-294 | Species | denotes | patients | Tax:9606 |
228 | 683-691 | Species | denotes | patients | Tax:9606 |
255 | 16-19 | Species | denotes | HBV | Tax:10407 |
256 | 151-154 | Species | denotes | HBV | Tax:10407 |
257 | 198-201 | Species | denotes | HBV | Tax:10407 |
258 | 336-339 | Species | denotes | HBV | Tax:10407 |
259 | 486-489 | Species | denotes | HBV | Tax:10407 |
260 | 512-515 | Species | denotes | HBV | Tax:10407 |
279 | 74-82 | Disease | denotes | COVID‐19 | MESH:C000657245 |
280 | 353-362 | Disease | denotes | mortality | MESH:D003643 |
281 | 429-442 | Disease | denotes | HBV infection | MESH:D006509 |
282 | 446-454 | Disease | denotes | COVID‐19 | MESH:C000657245 |
283 | 494-499 | Disease | denotes | COVID | MESH:C000657245 |
284 | 552-560 | Disease | denotes | COVID‐19 | MESH:C000657245 |
285 | 623-631 | Disease | denotes | COVID‐19 | MESH:C000657245 |
286 | 670-682 | Disease | denotes | HBV‐infected | MESH:D006509 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T65 | 74-82 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T66 | 433-442 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T67 | 446-454 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T68 | 494-502 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T69 | 552-560 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T70 | 623-631 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T71 | 711-720 | Disease | denotes | cirrhosis | http://purl.obolibrary.org/obo/MONDO_0005155 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T54 | 86-87 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T55 | 164-165 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T56 | 212-213 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T57 | 344-345 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T9 | 256-265 | Chemical | denotes | bilirubin | http://purl.obolibrary.org/obo/CHEBI_16990 |
T10 | 572-583 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
T11 | 585-600 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T35 | 0-11 | Sentence | denotes | Chen et al. |
T36 | 12-163 | Sentence | denotes | 10 HBV Retrospective analysis of hospitalized patients with COVID‐19 in a single center in Wuhan, China 12.2% (15/123) of patients were HBV infected |
T37 | 164-249 | Sentence | denotes | A higher percentage with comorbid HBV developed a severe outcome (46.7% versus 24.1%) |
T38 | 250-312 | Sentence | denotes | Total bilirubin level was higher in patients with comorbid HBV |
T39 | 313-502 | Sentence | denotes | Patients with comorbid HBV had a higher mortality rate (13.3% versus 2.8%) Heterogeneous data on the prevalence of HBV infection in COVID‐19 and on the interaction between HBV and COVID‐19 |
T40 | 503-601 | Sentence | denotes | Risk for HBV reactivation with some experimental COVID‐19 therapies (tocilizumab, corticosteroids) |
T41 | 602-720 | Sentence | denotes | Some investigational COVID‐19 medications may be contraindicated in HBV‐infected patients with decompensated cirrhosis |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T15 | 711-720 | Phenotype | denotes | cirrhosis | http://purl.obolibrary.org/obo/HP_0001394 |